Long-term outcome following surgical and radiation treatment of vertebral angiomatosis in a cat.

CASE DESCRIPTION A 2-year-old 5.2-kg (11.4-lb) neutered male domestic shorthair cat was referred because of a 6-week history of progressive paraparesis.

Evaluation of 12- and 24-month survival rates after treatment with masitinib in dogs with nonresectable mast cell tumors.

Objective: To evaluate the effectiveness of masitinib for the treatment of nonresectable mast cell tumors (MCTs) in dogs at 12 and 24 months after onset of treatment.

Animals: 132 dogs with nonresectable grade 2 or 3 MCTs.

Procedures: Dogs received masitinib (12.